[HTML][HTML] Optimizing antibiotic therapies to reduce the risk of bacterial resistance

S Bassetti, S Tschudin-Sutter, A Egli… - European journal of …, 2022 - Elsevier
The incidence of infections caused by bacteria that are resistant to antibiotics is constantly
increasing. In Europe alone, it has been estimated that each year about 33′ 000 deaths are …

[HTML][HTML] Leveraging diagnostic stewardship within antimicrobial stewardship programmes

KC Claeys, MD Johnson - Drugs in Context, 2023 - ncbi.nlm.nih.gov
Novel diagnostic stewardship in infectious disease consists of interventions that modify
ordering, processing, and reporting of diagnostic tests to provide the right test for the right …

ICU-acquired infections in immunocompromised patients

L Kreitmann, J Helms, I Martin-Loeches, J Salluh… - Intensive Care …, 2024 - Springer
Immunocompromised patients account for an increasing proportion of the typical intensive
care unit (ICU) case-mix. Because of the increased availability of new drugs for cancer and …

Antibiotic stewardship in the ICU: time to shift into overdrive

D Mokrani, J Chommeloux… - Annals of Intensive …, 2023 - Springer
Antibiotic resistance is a major health problem and will be probably one of the leading
causes of deaths in the coming years. One of the most effective ways to fight against …

Molecular diagnostics for genotypic detection of antibiotic resistance: current landscape and future directions

R Banerjee, R Patel - JAC-Antimicrobial Resistance, 2023 - academic.oup.com
Antimicrobial resistance (AMR) among bacteria is an escalating public health emergency
that has worsened during the COVID-19 pandemic. When making antibiotic treatment …

[HTML][HTML] Next-generation molecular diagnostics: Leveraging digital technologies to enhance multiplexing in real-time PCR

L Kreitmann, L Miglietta, K Xu… - TrAC Trends in …, 2023 - Elsevier
Real-time polymerase chain reaction (qPCR) enables accurate detection and quantification
of nucleic acids and has become a fundamental tool in biological sciences, bioengineering …

Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: A multicentre randomized controlled trial

M Fartoukh, S Nseir, B Mégarbane, Y Cohen… - Clinical Microbiology …, 2023 - Elsevier
Objectives We aimed at assessing the efficacy and safety on antibiotic exposure of a
strategy combining a respiratory multiplex PCR (mPCR) with enlarged panel and daily …

Incidence, microbiological and immunological characteristics of ventilator-associated pneumonia assessed by bronchoalveolar lavage and endotracheal aspirate in a …

D Mangioni, M Panigada, E Palomba, C Bobbio… - Critical Care, 2023 - Springer
Background No univocal recommendation exists for microbiological diagnosis of ventilator-
associated pneumonia (VAP). Sampling of either proximal or distal respiratory tract likely …

Ventilator-associated pneumonia in immunosuppressed patients

L Kreitmann, A Gaudet, S Nseir - Antibiotics, 2023 - mdpi.com
Immunocompromised patients—including patients with cancer, hematological malignancies,
solid organ transplants and individuals receiving immunosuppressive therapies for …

Antimicrobial stewardship and molecular diagnostics: a symbiotic approach to combating resistance in the ED and ICU

JJ De Waele, J Boelens - Current Opinion in Critical Care, 2024 - journals.lww.com
RMD hold great value in simplifying patient management and mitigating antimicrobial
exposure, particularly in settings with high levels of antimicrobial resistance where the use of …